Abstract
Previous studies have shown that polydatin (Poly) confer cardioprotective effects. However, its underlying mechanisms remain elusive. This study showed that Poly (10 µM) treatment reversed the high glucose (HG)-induced decrease in acetylcholine-elicited vasodilation in aortas. Poly also improved the acetylcholine-induced vasodilation of aortic vessels isolated from diabetic rats. Meanwhile, Poly ameliorated the morphological damage of the thoracic aorta and improved the viability of HUVECs under HG conditions. Furthermore, analysis of the vasoprotective effect of Poly under HG conditions by transmission electron microscopy, Western blotting, and qPCR revealed that Poly improved endothelial pyroptosis through the NLRP3/Caspase/1-IL-1β pathway, enhanced dynamin-related protein 1-mediated mitochondrial fission, and increased the mitochondrial membrane potential under HG conditions. In conclusion, Poly restored acetylcholine-induced vasodilation impaired by HG incubation, which was associated with reduced oxidation, inflammation, and pyroptosis, the recovery of the mitochondrial membrane potential and maintenance of mitochondrial dynamic homeostasis of endothelial cells in the aortas.
Similar content being viewed by others
Introduction
Persistent hyperglycemia in diabetes mellitus (DM) often leads to vascular complications1. The endothelium plays a pivotal role in the regulation of vascular tone by synthesizing and releasing an array of endothelium-derived relaxing factors. Hyperglycemia-induced endothelial disorder, characterized by compromised endothelium-dependent relaxation (EDR), is one of the typical pathophysiological mechanisms of vascular complications in DM2. Coupled with the combined effects of nitric oxide synthase (NOS) and other inflammatory factors, endothelial dysfunction in hyperglycemia leads to a redox imbalance in cells, which plays a key role in regulating vascular tone and maintaining vascular homeostasis2,3. Activation of inflammation subsequently lead to cellular dysfunction or injury via pyroptosis, a type of cell death that combines apoptotic and necrotic features4. Increasing evidence suggests that morphological and functional changes in the mitochondria are associated with vascular endothelial dysfunction. Moreover, the mitochondrial dynamic imbalance leads to mitochondrial breakage and disrupts endothelial physiological functions5.
Polydatin (Poly) extracted from the roots and rhizome of Reynoutria japonica is a widely used traditional Chinese medicine. It is also present in red wine, peanuts, hops pellets, chocolate, cocoa products, and various daily foods6. The biomedical properties of Poly include antiplatelet aggregation, antioxidation, cardioprotection, anti-inflammation, and immune regulation6. Poly treatment has been shown to normalize glucose and lipid metabolism, reverse insulin resistance, and reduce experimental diabetes-induced fibrosis7,8. Furthermore, Poly has been shown to restore EDR in aortic rings impaired by high glucose (HG) via the peroxisome proliferator-activated receptor alpha (PPARβ)/nitric oxide (NO) signaling pathway9. However, whether anti-inflammation, anti-pyroptosis, and mitochondrial dynamic homeostasis mediate the vasodilation effect of Poly remains elusive.
Herein, we hypothesize that Poly ameriolates HG-induced impairement of EDR by alleviating inflammation and oxidative stress (OS) and maintaining mitochondrial dynamic homeostasis of endothelial cells (ECs). This study will offer new insights into the study of the vasodilation effect of Poly.
Results
Effect of Poly on vasodilation under HG condition
After 6 h of incubation with HG, phenylephrine (PE) (1 µM, MedChemExpress, USA)-constricted aortic rings showed similar contractility to the normal glucose (NG) group (P > 0.05). Acetylcholine (Ach) (0.003–10 µM, Sigma, USA) caused a dose-dependent relaxation under the NG condition (Fig. 1A,D). ACh-induced vasodilation was significantly reduced in HG-incubated aortic rings (P < 0.05, Fig. 1B,D), which indicated impaired EDR. Poly (10 µM, TCI, Japan) improved the impaired ACh-induced vasodilation under HG condition (P < 0.05, Fig. 1C,D). In contrast, no significant difference was observed among groups in endothelium-independent vasodilation by SNP (Fig. 1E). In addition, Poly also decreased the acetylcholine-induced vasodilation of aortas isolated from diabetic rats (Supplementary Fig. 1). These results suggest that Poly may partially improve the decrease in endothelial-dependent relaxation in the aortic ring under HG conditions.
Effect of Poly on aortic ring morphology and viability of HUVECs
Hematoxylin and eosin (HE) staining data showed that the internal elastic lamina was disrupted after incubation for 6 h with HG. However, the aortic damages caused by HG were ameliorated by pretreatment with Poly (Fig. 2A).
To further investigate whether Poly could improve the viability of ECs incubated with HG, the cell counting (CCK-8) assay was performed on HUVECs. Results of the CCK-8 assay showed that the viability ratio of ECs decreased after incubation with HG (30 mM), which was significantly improved by Poly co-incubation with HG (Poly + HG) (P < 0.05, Fig. 2B). These results indicated that Poly ameliorated the morphological damages of the thoracic aorta and improved the viability of HUVECs under HG conditions.
Involvement of NOS in Poly’s action on aortic rings under HG condition
NO is a critical factor that regulates endothelium-dependent vasodilation in the aortas, which was commonly associated with endothelial NO synthase (eNOS)10. Our study showed that pre-incubation with L-NAME (100 µM, Sigma, USA), an eNOS inhibitor, completely abolished the amelioration of ACh-induced vasodilation by Poly under HG condition (Supplementary Fig. 2).
OS- or inflammation-induced inducible NOS (iNOS) contributes to severe endothelium injury and EDR9. Our results revealed that the expression level of eNOS decreased, while the expression level of iNOS increased significantly after incubation with HG (P < 0.05, Fig. 2C–E). However, Poly (10 µM) incubation reversed the expression changes in eNOS and iNOS of aortic rings (P < 0.05, Fig. 2C–E). The above results indicate that the impaired vasodilation of aortic rings under HG conditions was ameriolated through a mechanism involving upregulation of eNOS expression and downregulation of iNOS expression.
Effect of Poly on the free radical level
To investigate whether increased free radical levels contribute to the impaired relaxation of the aorta, the reactive oxygen species (ROS) level was lowered by a free radical scavenger tempol (100 µM, Sigma, USA). Immunofluorescence staining results showed that HG incubation increased ROS expression, and both the Poly and tempol significantly decreased the elevated ROS expression under HG conditions (P < 0.05, Fig. 3A,B). The effect of tempol incubation on ameliorating ACh-induced vasodilation under HG conditions was similar to that of Poly (Fig. 3C). Transmission electron microscopy (TEM) results demonstrated that HUVECs exposed to HG exhibited swelling and increased size, suggesting a potential disturbance in cellular balance. Additionally, the TEM images revealed a necrosis-like pattern in HUVECs exposed to HG, marked by compromised plasma membrane integrity and the release of cellular contents into the extracellular space. However, HUVECs incubated with Poly + HG showed almost normal ECs (Fig. 3D–F). These results indicate that Poly exerts a protective effect on the endothelium through anti-OS.
Effect of Poly on NOD-like receptor thermal protein domain associated protein 3 (NLRP3), vascular cell adhesion molecule 1 (VCAM-1), caspase-1 (CSP-1), and interleukin-1 beta (IL-1β) expression in aortic rings and cultured HUVECs under HG condition
To specifically determine whether Poly could reduce inflammation under HG conditions, we measured the protein levels of NLRP3, VCAM-1, CSP-1, and IL-1 β of the aortic ring in each group. As shown in Fig. 4, the protein levels of NLRP3, VCAM-1, CSP-1, and IL-1 β were increased following HG exposure (P < 0.05), which were reversed by pretreatment with Poly (10 µM) (P < 0.05, Fig. 4A–H).
HG treatment also increased protein levels of NLRP3, VCAM-1, CSP-1, and IL-1 β in HUVECs. Poly (10 µM) co-incubation with HG reversed the increased protein levels of NLRP3, VCAM-1, CSP-1, and IL-1β in HUVECs (P < 0.05, Fig. 5A–H). These data suggest that Poly improves inflammation and pyroptosis of endothelium through the NLRP3/CSP-1/IL-1β signaling pathway.
Effect of Poly on the mitochondrial membrane potential (MMP) of cultured HUVECs under HG condition
ROS in cells mainly comes from the mitochondria11. The MMP plays a key role in mitochondrial homeostasis, and a decrease or increase of MMP in cells may lead to cell viability loss and is a factor in various diseases12. A fluorescent probe 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolylcarbocyanine iodide (JC-1) was used to test the effect of Poly on MMP. Results showed that the JC-1 aggregate/monomer ratio was decreased after incubation with HG, which was reversed after Poly co-incubation with HG (P < 0.05, Fig. 6). The above results suggest that Poly restored the decreased MMP of HUVECs under HG conditions.
Effect of Poly on mitochondrial dynamic homeostasis in aortic rings and cultured HUVECs under HG condition
Dynamin-related protein-1 (Drp1), which regulates mitochondrial fission, is also involved in the maintenance of mitochondrial homeostasis. Drp1 overexpression resulted in abundant mitochondrial fission, ROS accumulation, and loss of MMP13,14. To examine whether Poly could modulate mitochondrial dynamic homeostasis, we measured the protein levels of total Drp1 and phosphorylated Drp1 (p-Drp1, Ser637) in aortas and HUVECs. The level of Drp1 protein was increased significantly in the aorta and HUVECs after HG incubation compared with NG incubation (P < 0.05). However, Poly pretreatment significantly reversed this effect (P < 0.05, Figs. 7A,B and 8A,B). The protein levels of p-Drp1 (Ser637) were markedly reduced (P < 0.05), while the application of Poly significantly increased the levels of p-Drp1 (Ser637) in the aortas (P < 0.05, Supplementary Fig. 3A) and HUVECs (P < 0.05, Supplementary Fig. 3B). Furthermore, the p-Drp1/Drp1 ratio was significantly lower in the HG group relative to the NG group and increased in the Poly + HG group compared with the HG group in the aortas (P < 0.05, Fig. 7C) and HUVECs (P < 0.05, Fig. 8C).
Mitochondrial fission protein 1 (FIS1) plays a central part in mitochondrial fission15. We tested the protein levels of FIS1 in the aortas and HUVECs. No significant differences in FIS1 protein expressions in the aortas (P > 0.05, Fig. 7D,E) and HUVECs (P > 0.05, Fig. 8D,E) were found among NG, HG, and Poly + HG groups.
Integral membrane proteins mitofusin 1 (MFN1) and mitofusin 2 (MFN2) mediate the fusion of adjacent mitochondrial outer membranes, while optic atrophy 1 (OPA1) mediates the inner membrane fusion and cristae remodeling15. To explore whether Poly affects the mitochondrial fusion of ECs, we measured the protein expression level of MFN1, MFN2, and OPA1 in the aortas and HUVECs. The results showed that neither HG nor Poly affected the protein expressions of MFN1, MFN2, and OPA1 in the aortas (P > 0.05, Fig. 7F–K) and HUVECs (P > 0.05, Fig. 8F–K). These results indicate that Poly protects aortas and HUVECs from HG injury by improving Drp1-mediated mitochondrial fission.
Discussion
The present study investigated whether Poly can ameliorate the vasodilation effects HG on rat aortic rings and the potential underlying mechanisms. The results showed that Poly effectively attenuated endothelium-dependent vasodilation induced by HG, which was abolished by the eNOS inhibitor L-NAME. In addition, Poly alleviated HG-induced morphological impairment of the aortic ring, increased the expression of eNOS, and decreased the expression of iNOS under HG conditions. Meanwhile, Poly decreased the elevated ROS level, inflammatory response, and pyroptosis. Furthermore, Poly recovered the decreased MMP and p-Drp1 (Ser637) levels but increased the total Drp1 levels under HG conditions in both the aortas and HUVECs. Overall, our study suggested that Poly restores endothelial-induced vasodilation by alleviating OS, inflammation, and pyroptosis and improving mitochondrial function and dynamics under HG conditions.
NOS is expressed in the nervous system and consists of three isoforms of its isoenzymes: neuronal nitric oxide synthase (nNOS) and eNOS, which are expressed in normal conditions, and iNOS, which is expressed following injury. NO derived from eNOS had endothelial protective effects9,16. However, NO derived from iNOS and nNOS had endothelial toxic effects17. Consistent with previous studies9, our results showed that Poly reversed the adverse effects of HG on ACh-induced vasodilation in aortic rings and the cell viability of HUVECs. The enhanced EDR of Poly under HG condition was obstructed by the eNOS inhibitor L-NAME. We also demonstrated that HG resulted in a marked decrease in eNOS protein levels and an increase in iNOS protein levels in the aortas. However, pretreatment with Poly reversed the protein expression changes in eNOS and iNOS. Meanwhile, Poly also improved the morphological injury of aortic rings induced by HG incubation. These results suggested that the eNOS-NO system is involved in the ameliorative effect of Poly on impaired EDR caused by HG.
Inflammation is one of the factors that trigger endothelial dysfunction in the pathophysiology of diabetic macrovascular disorders. Several studies have confirmed the anti-inflammatory activity of Poly in the prevention of heart and neurodegenerative diseases6, steatohepatitis18, fructose-induced liver inflammation19, and adipose tissue inflammation20. NLRP3 is a member of the nucleotide-binding domain-(NOD)-like receptor family21, and NLRP3 inflammasome-mediated inflammation and pyroptosis play a key role in vascular endothelial dysfunction22. Previous studies showed that the NLRP3 inflammasome promotes endothelial inflammation under HG conditions23,24. In addition, VCAM-1 is expressed in ECs and mediates leukocyte adhesion in response to cytokines such as tumor necrosis factor-alpha and IL-1β25,26,27, and further activates endothelial signals to induce vascular damage28. We showed that Poly (10 µM) reversed the increased protein expressions of NLRP3, VCAM-1, IL-1β, and CSP-1 in aortic rings and HUVECs after HG incubation. Our results indicate that Poly may alleviate the inflammatory response in the endothelium of aortic rings and HUVECs under HG conditions.
Pyroptosis is a type of inflammatory cell death that combines apoptotic and necrotic characteristics and is mediated by pyroptotic caspases, such as CSP-1 activation29, which is responsible for the cleavage of IL-1β and IL-18. It has been shown that pyroptosis plays an essential role in cardiovascular diseases30,31, diabetic heart disease32, and cardiac ischemia–reperfusion injury33. The caspase-cascade system is involved in the initiation, transduction, and amplification of tissue and cell apoptosis34. Our TEM results showed that Poly alleviated the disruption of HUVECs induced by HG. We hypothesize that Poly might attenuate pyroptosis of HUVECs exposed to HG. Collectively, the findings of this study indicate that Poly can improve endothelial pyroptosis induced by HG via the NLRP3/CSP-1/IL-1β signaling pathway.
ROS are generated as by-products of cellular metabolism, primarily in the mitochondria35,36,37. When the electron transport chain on the inner mitochondrial membrane is disrupted by hyperglycemia in diabetes, ROS accumulate in the cell and become toxic after reaching a certain level30,38, which leads to mitochondrial dysfunction39,40. In addition to being a primary source of ROS, mitochondria are also the targets of ROS. The MMP plays a key role in mitochondrial homeostasis and a decrease in MMP in the cell may reduce cell viability loss12. We showed that the MMP was decreased after HG incubation, whereas this effect was improved by Poly co-incubation with HG. Excessive ROS damages mitochondrial proteins, messenger RNA, and membrane lipids and decreases the MMP, resulting in endothelial dysfunction41,42,43,44,45, which could be rescued by Poly.
The dynamic transition of the mitochondria that coordinates fission and fusion cycles plays a vital role in mitochondrial homeostasis46. Mitochondrial fission was regulated by the recruitment of the GTPase Drp1 and overexpression of Drp1 resulted in excessive mitochondrial fission, ROS accumulation, and loss of MMP13,14. Conversely, phosphorylation of Drp1 at Ser637 inhibited mitochondrial fission47. As another integral membrane protein, FIS1 participates in mitochondrial fission. It plays an important role in the regulation of mitochondrial fission as a pro-apoptotic factor48. It interacts with Drp1 and facilitates the functional fission complex formation, thereby inducing apoptosis. Our study found that the expression of Drp1 increased in the presence of HG, whereas Ser637 phosphorylation of Drp1 and the p-Drp1/Drp1 ratio was notably decreased in both the aortas and HUVECs. However, Poly significantly decreased these changes under HG conditions. Moreover, neither HG nor Poly affected the expression of FIS1 in the aortas and HUVECs. Overall, these changes were due to a decline in mitochondrial fission and fragmentation associated with hyperglycemia. Our data showed that hyperglycemia induced an increase in Drp1 and a decrease in p-Drp1 (Ser637) in the aortas and HUVECs, which was reversed by Poly. We also found that neither HG nor Poly affected mitochondrial fusion-related protein expressions of MFN1, MFN2, and OPA1 in the aortas and HUVECs, implying that Poly does not affect mitochondrial fusion under HG conditions.
One limitation of this study is that it was conducted solely in animals and ex vivo. Although the results in HUVECs and aortas of the diabetic rat model provide important insights, the applicability of these findings in clinical settings is limited. Further validation is required to ascertain the impact of Poly on chronic hyperglycemia, especially in diabetic patients. Moreover, this study primarily centered on the broad-spectrum effect of Poly on vascular endothelial cells, without delving into the specific upstream and downstream signaling pathways. Therefore, the mechanistic insights are correlative, and additional investigations are needed to elucidate the precise mechanisms by which Poly modulates inflammation, oxidative stress, and mitochondrial function.
Conclusion
In summary, Poly restores ACh-induced vasodilation impaired by HG incubation, which might be associated with a reduction in the OS, inflammation, and pyroptosis, recovery of MMP, and improvement of mitochondrial dynamics of aortic ECs.
Experimental protocol
Experimental animals
Thirteen-week-old male adult Sprague–Dawley rats were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China). Rats were kept in a constant temperature room with an artificially controlled light/dark cycle (12/12 h), with free access to food and water. To establish the DM animal model, 6 rats were randomly selected to intraperitoneally injected with streptozotocin (STZ) (60 mg/kg/d in 0.1 mM sodium citrate buffer; Sigma, St. Louis, MO, USA) for 7 days. The experiments were carried out followed the National Research Council’s (NRC) Guide for the Care and Use of Laboratory Animals and the ARRIVE 2.0 guideline49, and all techniques and procedures were approved by the Hebei Medical University Ethics Committee for the Use of Laboratory Animals.
Preparation of isolated thoracic aortic rings
Rats were anesthetized with 3% isoflurane inhalation. Then rats’ thoracic aortas (3–4 mm long) were dissected and randomly divided into three groups: NG group, HG group, and Poly + HG group. Poly was dissolved in 0.5% dimethysulfoxide (DMSO) and directly diluted in the medium to a concentration of 10 µM for further experiments. The concentration of Poly was determined based on the literatures50,51 and our preliminary experiment (Supplementary Figs. 4 and 5). All vascular tissues were carefully separated from connective tissues and placed in organ bath chambers filled with the Krebs–Henseleit (K-H) buffer saturated with 95% oxygen and 5% carbon dioxide (CO2) at 37 °C. The K-H buffer consisted of (in mM): 118 NaCl, 4.7 KCl, 2.5 CaCl2, 1.2 MgSO4, 25.0 NaHCO3, 1.2 KH2PO4, and 11.0 glucose (pH 7.35–7.4).
Measurement of vascular tone
An organ bath system (Chengdu Instrument Company, Chengdu, China) was used to record the vascular tension. Aortic rings were normalized with an optimal pre-tension and stabilized for 30 min. The contraction of the aortic ring was induced with KCl (60 mM) and PE (1 µM), respectively. The relaxation of the aortic rings was induced by ACh (0.003–10 µM) or sodium nitroprusside (SNP, 0.001–1 µM). ECs were considered intact and data were included if ACh-induced vasodilation in the aortic rings exceeded 80% of PE (1 µM)-induced constriction. Data were excluded if the diastole of the aortic rings was less than 80%. Aortic rings were incubated in K-H solution containing NG (11 mM), HG (55 mM), or Poly (10 µM) + HG (55 mM) for 6 h. In another set of experiments, aortic rings were co-incubated with endothelial NOS (eNOS) inhibitor L-NAME (100 µM) or ROS scavenger tempol (100 µM) for 6 h together with Poly + HG solution. Vessel rings were rinsed with the K-H buffer to remove the effect of the drugs and allow restoration of the aortic tension.
Histological observation
Aortic tissues were fixed with 4% paraformaldehyde and then embedded in paraffin. The tissue was cut using a microtome into sections with a thickness of 4 µm. The paraffin was then removed and the sections were stained with H&E and observed under a light microscope.
CCK-8 assay
Human umbilical vein endothelial cells (HUVECs) were supplied by ScienCell Research Laboratories and maintained in an endothelial cell medium (ECM, No. 1001, ScienCell, USA) supplemented with 10% fetal bovine serum (Gibco), 100 U/mL penicillin, and 100 U/mL streptomycin. HUVECs were treated with normal medium (NG), 30 mM glucose medium (HG), and 10 µM Poly + 30 mM glucose medium (Poly + HG) for 48 h. HUVECs were incubated in a humidified incubator with 5% CO2 at 37 °C.
Cell viability was measured using the CCK-8 assay (APExBIO, Houston, USA). Cells were seeded in 96-well plates at 5 × 103 cells per well. Then, cells were incubated with 10 µL CCK-8 solution for another 2 h. The absorbance was detected at 450 nm using a microplate reader (Autobio Diagnostics Co, Ltd., Zhengzhou, China).
ROS measurement
Aortic tissues were embedded in optimum cutting temperature compound (OCT, Sakura, Japan), sliced into 8-µm sections using a cryostat microtome, and stored at − 20 °C after labeling. Frozen slides were returned to room temperature. Next, the slides were washed for 10 min and stained with ROS staining solution (Sigma, USA) after quenching. Slides were observed under fluorescent microscopy and the images were obtained.
Observation of the cellular ultrastructure under TEM
After fixing with glutaraldehyde, specimens were gradient dehydrated with ethanol and then transferred to acetone (Sigma-Aldrich, MOUSA) for 15 min. Specimens were then incubated with absolute acetone and a final EPON resin mixture overnight. Next, specimens were embedded in a medium in a capsule for 48 h. Finally, sections were stained and observed under Hitachi TEM at 7000 × magnification.
MMP measurement
The MMP of ECs were analyzed using JC-1 fluorescent probe (No. G1515-100T, Servicebio). Cells in different groups were rinsed with a JC-1 washing buffer and incubated with JC-1 (10 µM) at 37 °C for 30 min. Afterward, cells were rinsed with a washing buffer. The MMP was examined under a fluorescence microscope (Leica, DM6000/DFC310FX). Fluorescence wavelength parameters were adjusted to an excitation wavelength (Ex) of 490 nm and emission wavelength (Em) of 525 nm to detect the JC-1 monomer, and an Ex of 525 nm and Em of 590 nm to detect the JC-1 aggregate. The MMP was represented by a fluorescence ratio of JC-1 aggregate/monomer (red/green). The value of the NG group was set as the standard to normalize the value of the HG and Poly + HG groups.
Western blotting
The effect of the Poly on protein expression of eNOS, inducible NOS (iNOS), NLRP3, VCAM-1, CSP-1, IL-1β, Drp1, p-Drp1, FIS1, MFN1, MFN2, and OPA1 in the aortas and HUVECs were evaluated using western blotting. Aortic tissues and HUVECs were homogenized on ice in RIPA lysis/extraction buffer (No. BB-3201, BestBio) containing protease and phosphatase inhibitors (No. RP-WA0103, Reportbio; No. HY-K0010, MCE) for 30 min. Samples were centrifuged at 16,000 g for 15 min at 4 °C and the supernatant was obtained. About 50 µg of protein from each sample was separated by 10% sodium dodecyl-sulfate polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane. The membranes were incubated with the following primary antibodies: mouse monoclonal anti-eNOS (1:1000, No. 610296, BD Biosciences), rabbit polyclonal anti-iNOS (1:1000, No. ARG56509, Arigobio), rabbit monoclonal anti-NLRP3 (1:1000, No. ET1610-93, HUABIO), mouse monoclonal anti-VCAM-1 (1:1000, No. 66294-1-lg, Proteintech), rabbit polyclonal anti-CSP-1 (1:1000, No. 22915-1-AP, Proteintech), rabbit polyclonal anti-IL-1β (1:1000, No. 16806-1-AP, Proteintech), rabbit polyclonal anti-Drp1 (1:1000, No. 12957-1-AP, Proteintech), rabbit polyclonal anti-pDrp1 (1:1000, No. 3455S, Cell Signal), rabbit polyclonal anti-FIS1 (1:1000, No. 10956-1-AP, Proteintech), rabbit polyclonal anti-MFN1 (1:1000, No. 13798-1-AP, Proteintech), rabbit polyclonal anti-MFN2 (1:1000, No. 12186-1-AP, Proteintech), rabbit polyclonal anti-OPA1 (1:1000, No. 27733-1-AP, Proteintech), and rabbit polyclonal anti-GAPDH (1:1000, No. 60004-1-lg, Proteintech) overnight at 4 °C. Protein bands were detected using an Immobilon™ Western Chemiluminescent HRP Substrate (1:10,000, No. S1001-100 and No. S1002, SeraCare), and images were visualized on a ChemiScope S6 imaging system (CLiNX, China).
Statistical analysis
Data were expressed as means ± SEM. Statistical analyses were performed using Prism 8 (GraphPad Software Inc., La Jolla, CA). One-way or two-way ANOVA followed by Tukey’s test was used to compare the groups. P < 0.05 was considered statistically significant.
Ethical approval
The experiments were carried out in accordance with the NRC Guide for the Care and Use of Laboratory Animals, and all techniques and procedures were approved by the Hebei Medical University Ethics Committee for the Use of Laboratory Animals.
Data availability
Data are available on request from the corresponding author.
References
Chawla, A., Chawla, R. & Jaggi, S. Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J. Endocrinol. Metab. 20(4), 546–551 (2016).
Meza, C. A. et al. Endothelial dysfunction: Is there a hyperglycemia-induced imbalance of NOX and NOS?. Int. J. Mol. Sci. 20(15), 3775 (2019).
Su, J. B. Vascular endothelial dysfunction and pharmacological treatment. World J. Cardiol. 7(11), 719–741 (2015).
Schroder, K. & Tschopp, J. The inflammasomes. Cell 140(6), 821–832 (2010).
Pangare, M. & Makino, A. Mitochondrial function in vascular endothelial cell in diabetes. J. Smooth Muscle Res. 48(1), 1–26 (2012).
Du, Q. H., Peng, C. & Zhang, H. Polydatin: A review of pharmacology and pharmacokinetics. Pharm. Biol. 51(11), 1347–1354 (2013).
Xie, X. et al. Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells. Mol. Cell. Endocrinol. 362(1–2), 183–193 (2012).
Gao, J. P. et al. Effects of polydatin on attenuating ventricular remodeling in isoproterenol-induced mouse and pressure-overload rat models. Fitoterapia 81(7), 953–960 (2010).
Wu, Y. et al. Polydatin restores endothelium-dependent relaxation in rat aorta rings impaired by high glucose: A novel insight into the PPARbeta-NO signaling pathway. PLOS ONE 10(5), e0126249 (2015).
Wu, Y. et al. ATRA improves endothelial dysfunction in atherosclerotic rabbits by decreasing CAV1 expression and enhancing eNOS activity. Mol. Med. Rep. 17(5), 6796–6802 (2018).
Suski, J. M. et al. Relation between mitochondrial membrane potential and ROS formation. Methods Mol. Biol. 810, 183–205 (2012).
Zorova, L. D. et al. Mitochondrial membrane potential. Anal. Biochem. 552, 50–59 (2018).
Luo, X. et al. Drp-1 as potential therapeutic target for lipopolysaccharide-induced vascular hyperpermeability. Oxid. Med. Cell. Longev. 2020, 5820245 (2020).
Haileselassie, B. et al. Drp1/Fis1 interaction mediates mitochondrial dysfunction in septic cardiomyopathy. J. Mol. Cell. Cardiol. 130, 160–169 (2019).
Ihenacho, U. K. et al. Mitochondrial fission protein 1: Emerging roles in organellar form and function in health and disease. Front. Endocrinol. (Lausanne) 12, 660095 (2021).
Jiang, B. et al. Overexpression of endothelial nitric oxide synthase improves endothelium-dependent vasodilation in arteries infused with helper-dependent adenovirus. Hum. Gene Ther. 23(11), 1166–1175 (2012).
Qi, J. et al. High glucose induces endothelial COX2 and iNOS expression via inhibition of monomethyltransferase SETD8 expression. J. Diabetes Res. 2020, 2308520 (2020).
Li, R. et al. Polydatin attenuates diet-induced nonalcoholic steatohepatitis and fibrosis in mice. Int. J. Biol. Sci. 14(11), 1411–1425 (2018).
Zhao, X. J. et al. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway. Redox Biol. 18, 124–137 (2018).
Zheng, L. et al. Polydatin inhibits adipose tissue inflammation and ameliorates lipid metabolism in high-fat-fed mice. Biomed. Res. Int. 2019, 7196535 (2019).
Kelley, N. et al. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation. Int. J. Mol. Sci. 20(13), 3328 (2019).
Bai, B. et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 11(9), 776 (2020).
Wan, Z. et al. NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis. Diabetes Metab. Syndr. Obes. 12, 1931–1942 (2019).
Stienstra, R. et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. U S A 108(37), 15324–15329 (2011).
Muller, W. A. Localized signals that regulate transendothelial migration. Curr. Opin. Immunol. 38, 24–29 (2016).
Huang, A. J. et al. Endothelial cell cytosolic free calcium regulates neutrophil migration across monolayers of endothelial cells. J. Cell Biol. 120(6), 1371–1380 (1993).
Chen, H. et al. Chronic intermittent hypobaric hypoxia decreases high blood pressure by stabilizing the vascular renin-angiotensin system in spontaneously hypertensive rats. Front. Physiol. 12, 639454 (2021).
Wechsler, M. E. et al. Eosinophils in health and disease: A state-of-the-art review. Mayo Clin. Proc. 96(10), 2694–2707 (2021).
Jia, C. et al. Role of pyroptosis in cardiovascular diseases. Int. Immunopharmacol. 67, 311–318 (2019).
Zhang, Y. et al. Melatonin prevents endothelial cell pyroptosis via regulation of long noncoding RNA MEG3/miR-223/NLRP3 axis. J. Pineal Res. 64(2), e12449 (2018).
Wu, X. et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis. 9(2), 171 (2018).
Li, X. et al. MicroRNA-30d regulates cardiomyocyte pyroptosis by directly targeting foxo3a in diabetic cardiomyopathy. Cell Death Dis. 5, e1479 (2014).
Qiu, Z. et al. NLRP3 inflammasome activation-mediated pyroptosis aggravates myocardial ischemia/reperfusion injury in diabetic rats. Oxid. Med. Cell. Longev. 2017, 9743280 (2017).
Shu, S. Y. et al. Effect of polydatin on phospholipase A2 in lung tissues in rats with endotoxic shock. Chin. J. Traumatol. 7(4), 239–243 (2004).
Murphy, M. P. How mitochondria produce reactive oxygen species. Biochem. J. 417(1), 1–13 (2009).
Zorov, D. B., Juhaszova, M. & Sollott, S. J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev. 94(3), 909–950 (2014).
Thannickal, V. J. & Fanburg, B. L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 279(6), L1005–L1028 (2000).
Abais, J. M. et al. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?. Antioxid. Redox Signal. 22(13), 1111–1129 (2015).
Xu, S. et al. Palmitate induces ER calcium depletion and apoptosis in mouse podocytes subsequent to mitochondrial oxidative stress. Cell Death Dis 6(11), 331 (2015).
Chong, C. R., Clarke, K. & Levelt, E. Metabolic remodeling in diabetic cardiomyopathy. Cardiovasc. Res. 113(4), 422–430 (2017).
Fetterman, J. L. et al. Mitochondrial DNA damage and vascular function in patients with diabetes mellitus and atherosclerotic cardiovascular disease. Cardiovasc. Diabetol. 15(53), 016–0372 (2016).
Cadenas, E. & Davies, K. J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med. 29(3–4), 222–230 (2000).
Rovira-Llopis, S. et al. Mitochondrial dynamics in type 2 diabetes: Pathophysiological implications. Redox Biol. 11, 637–645 (2017).
Gioscia-Ryan, R. A. et al. Mitochondria-targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice. J. Physiol. 592(12), 2549–2561 (2014).
Shenouda, S. M. et al. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 124(4), 444–453 (2011).
Tilokani, L. et al. Mitochondrial dynamics: Overview of molecular mechanisms. Essays Biochem. 62(3), 341–360 (2018).
Knott, A. B. et al. Mitochondrial fragmentation in neurodegeneration. Nat. Rev. Neurosci. 9(7), 505–518 (2008).
Zhang, Z. et al. Fis1 deficiencies differentially affect mitochondrial quality in skeletal muscle. Mitochondrion 49, 217–226 (2019).
Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLOS Biol. 18(7), e3000410 (2020).
Bader, M. et al. Polydatin restores endothelium-dependent relaxation in rat aorta rings impaired by high glucose: A novel insight into the PPARβ-NO signaling pathway. Plos One 10(5), e126249 (2015).
Matacchione, G. et al. Curcumin, polydatin and quercetin synergistic activity protects from high-glucose-induced inflammation and oxidative stress. Antioxidants 11(6), 1037 (2022).
Supplementary information
Supplemental file uncropped Western blot.
Funding
This study was supported by the National Natural Sciences Foundation of China (Nos. 31971044, 81770307, 81800308), the Natural Science Foundation of Hebei Province (Nos. H2019206325, H2019206246, H2020206478, H2021206055, H2021206203), and Projects of Medical Science Research of Health Commission of Hebei Province, China (Nos. 20200857, 20210513).
Author information
Authors and Affiliations
Contributions
H.J.M., J.H.D., W.S., and Q.Y.Z. contributed to conception and design of the study. S.W., M.M.Z., H.Y.M. and Y.G. organized the database and performed the statistical analysis. W.S. wrote the first draft of the manuscript. Y.Z., Y.L., C.H.Z., W.S. and X.J.Z. wrote sections of the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Shah, W., Zhao, Q., Wang, S. et al. Polydatin improves vascular endothelial function by maintaining mitochondrial homeostasis under high glucose conditions. Sci Rep 13, 16550 (2023). https://doi.org/10.1038/s41598-023-43786-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-43786-4
- Springer Nature Limited